nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoprolol—SLC22A2—Cladribine—multiple sclerosis	0.248	0.338	CbGbCtD
Metoprolol—CYP2D6—Fingolimod—multiple sclerosis	0.0964	0.132	CbGbCtD
Metoprolol—ABCB1—Methylprednisolone—multiple sclerosis	0.0659	0.0901	CbGbCtD
Metoprolol—CYP2C19—Prednisone—multiple sclerosis	0.0495	0.0676	CbGbCtD
Metoprolol—ABCB1—Mitoxantrone—multiple sclerosis	0.0481	0.0657	CbGbCtD
Metoprolol—ABCB1—Betamethasone—multiple sclerosis	0.0429	0.0586	CbGbCtD
Metoprolol—ABCB1—Prednisolone—multiple sclerosis	0.0423	0.0578	CbGbCtD
Metoprolol—ABCB1—Prednisone—multiple sclerosis	0.0399	0.0546	CbGbCtD
Metoprolol—CYP2C19—Dexamethasone—multiple sclerosis	0.0309	0.0422	CbGbCtD
Metoprolol—ABCB1—Dexamethasone—multiple sclerosis	0.0249	0.0341	CbGbCtD
Metoprolol—CYP2D6—Dexamethasone—multiple sclerosis	0.0235	0.0321	CbGbCtD
Metoprolol—ABCB1—Methotrexate—multiple sclerosis	0.02	0.0274	CbGbCtD
Metoprolol—Chlorphenesin—BCHE—multiple sclerosis	0.000458	1	CrCbGaD
Metoprolol—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000289	0.00116	CcSEcCtD
Metoprolol—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000287	0.00115	CcSEcCtD
Metoprolol—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000286	0.00115	CcSEcCtD
Metoprolol—Shock—Prednisolone—multiple sclerosis	0.000285	0.00114	CcSEcCtD
Metoprolol—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000285	0.00114	CcSEcCtD
Metoprolol—Tachycardia—Prednisolone—multiple sclerosis	0.000283	0.00113	CcSEcCtD
Metoprolol—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000283	0.00113	CcSEcCtD
Metoprolol—Hypertension—Triamcinolone—multiple sclerosis	0.000282	0.00113	CcSEcCtD
Metoprolol—Hypertension—Methylprednisolone—multiple sclerosis	0.000281	0.00113	CcSEcCtD
Metoprolol—Urticaria—Mitoxantrone—multiple sclerosis	0.000281	0.00113	CcSEcCtD
Metoprolol—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00028	0.00112	CcSEcCtD
Metoprolol—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000279	0.00112	CcSEcCtD
Metoprolol—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000279	0.00112	CcSEcCtD
Metoprolol—Vomiting—Azathioprine—multiple sclerosis	0.000278	0.00111	CcSEcCtD
Metoprolol—Pneumonia—Methotrexate—multiple sclerosis	0.000278	0.00111	CcSEcCtD
Metoprolol—Arthralgia—Methylprednisolone—multiple sclerosis	0.000277	0.00111	CcSEcCtD
Metoprolol—Eye disorder—Prednisone—multiple sclerosis	0.000277	0.00111	CcSEcCtD
Metoprolol—Anxiety—Methylprednisolone—multiple sclerosis	0.000277	0.00111	CcSEcCtD
Metoprolol—Rash—Azathioprine—multiple sclerosis	0.000276	0.00111	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000276	0.00111	CcSEcCtD
Metoprolol—Dermatitis—Azathioprine—multiple sclerosis	0.000275	0.0011	CcSEcCtD
Metoprolol—Depression—Methotrexate—multiple sclerosis	0.000275	0.0011	CcSEcCtD
Metoprolol—Headache—Azathioprine—multiple sclerosis	0.000274	0.0011	CcSEcCtD
Metoprolol—Dry mouth—Triamcinolone—multiple sclerosis	0.000272	0.00109	CcSEcCtD
Metoprolol—Angiopathy—Prednisone—multiple sclerosis	0.000269	0.00108	CcSEcCtD
Metoprolol—Conjunctivitis—Methotrexate—multiple sclerosis	0.000268	0.00108	CcSEcCtD
Metoprolol—Confusional state—Methylprednisolone—multiple sclerosis	0.000268	0.00108	CcSEcCtD
Metoprolol—Immune system disorder—Prednisone—multiple sclerosis	0.000268	0.00107	CcSEcCtD
Metoprolol—Oedema—Triamcinolone—multiple sclerosis	0.000267	0.00107	CcSEcCtD
Metoprolol—Vertigo—Dexamethasone—multiple sclerosis	0.000266	0.00107	CcSEcCtD
Metoprolol—Vertigo—Betamethasone—multiple sclerosis	0.000266	0.00107	CcSEcCtD
Metoprolol—Syncope—Betamethasone—multiple sclerosis	0.000266	0.00107	CcSEcCtD
Metoprolol—Syncope—Dexamethasone—multiple sclerosis	0.000266	0.00107	CcSEcCtD
Metoprolol—Arrhythmia—Prednisone—multiple sclerosis	0.000265	0.00106	CcSEcCtD
Metoprolol—Sweating—Methotrexate—multiple sclerosis	0.000265	0.00106	CcSEcCtD
Metoprolol—Shock—Triamcinolone—multiple sclerosis	0.000262	0.00105	CcSEcCtD
Metoprolol—Insomnia—Prednisolone—multiple sclerosis	0.000262	0.00105	CcSEcCtD
Metoprolol—Alopecia—Prednisone—multiple sclerosis	0.000262	0.00105	CcSEcCtD
Metoprolol—Shock—Methylprednisolone—multiple sclerosis	0.000262	0.00105	CcSEcCtD
Metoprolol—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000261	0.00105	CcSEcCtD
Metoprolol—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000261	0.00105	CcSEcCtD
Metoprolol—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000261	0.00105	CcSEcCtD
Metoprolol—Loss of consciousness—Betamethasone—multiple sclerosis	0.000261	0.00105	CcSEcCtD
Metoprolol—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00026	0.00104	CcSEcCtD
Metoprolol—Paraesthesia—Prednisolone—multiple sclerosis	0.00026	0.00104	CcSEcCtD
Metoprolol—Tachycardia—Triamcinolone—multiple sclerosis	0.00026	0.00104	CcSEcCtD
Metoprolol—Mental disorder—Prednisone—multiple sclerosis	0.00026	0.00104	CcSEcCtD
Metoprolol—Nausea—Azathioprine—multiple sclerosis	0.00026	0.00104	CcSEcCtD
Metoprolol—Tachycardia—Methylprednisolone—multiple sclerosis	0.00026	0.00104	CcSEcCtD
Metoprolol—Skin disorder—Methylprednisolone—multiple sclerosis	0.000258	0.00104	CcSEcCtD
Metoprolol—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000258	0.00103	CcSEcCtD
Metoprolol—Agranulocytosis—Methotrexate—multiple sclerosis	0.000258	0.00103	CcSEcCtD
Metoprolol—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000257	0.00103	CcSEcCtD
Metoprolol—Hypertension—Betamethasone—multiple sclerosis	0.000256	0.00103	CcSEcCtD
Metoprolol—Hypertension—Dexamethasone—multiple sclerosis	0.000256	0.00103	CcSEcCtD
Metoprolol—Asthenia—Mitoxantrone—multiple sclerosis	0.000254	0.00102	CcSEcCtD
Metoprolol—Anxiety—Betamethasone—multiple sclerosis	0.000251	0.00101	CcSEcCtD
Metoprolol—Anxiety—Dexamethasone—multiple sclerosis	0.000251	0.00101	CcSEcCtD
Metoprolol—Hypotension—Methylprednisolone—multiple sclerosis	0.000249	0.000997	CcSEcCtD
Metoprolol—Pain—Prednisolone—multiple sclerosis	0.000248	0.000994	CcSEcCtD
Metoprolol—Hepatitis—Methotrexate—multiple sclerosis	0.000248	0.000994	CcSEcCtD
Metoprolol—Vision blurred—Prednisone—multiple sclerosis	0.000243	0.000976	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000243	0.000974	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000242	0.000972	CcSEcCtD
Metoprolol—Oedema—Betamethasone—multiple sclerosis	0.000242	0.00097	CcSEcCtD
Metoprolol—Oedema—Dexamethasone—multiple sclerosis	0.000242	0.00097	CcSEcCtD
Metoprolol—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000242	0.00097	CcSEcCtD
Metoprolol—Insomnia—Triamcinolone—multiple sclerosis	0.000241	0.000967	CcSEcCtD
Metoprolol—Insomnia—Methylprednisolone—multiple sclerosis	0.000241	0.000965	CcSEcCtD
Metoprolol—Paraesthesia—Triamcinolone—multiple sclerosis	0.000239	0.00096	CcSEcCtD
Metoprolol—Feeling abnormal—Prednisolone—multiple sclerosis	0.000239	0.000958	CcSEcCtD
Metoprolol—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000239	0.000958	CcSEcCtD
Metoprolol—Visual impairment—Methotrexate—multiple sclerosis	0.000239	0.000958	CcSEcCtD
Metoprolol—Shock—Dexamethasone—multiple sclerosis	0.000238	0.000955	CcSEcCtD
Metoprolol—Shock—Betamethasone—multiple sclerosis	0.000238	0.000955	CcSEcCtD
Metoprolol—Dyspnoea—Triamcinolone—multiple sclerosis	0.000238	0.000953	CcSEcCtD
Metoprolol—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000237	0.000952	CcSEcCtD
Metoprolol—Nervous system disorder—Betamethasone—multiple sclerosis	0.000237	0.000952	CcSEcCtD
Metoprolol—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000237	0.00095	CcSEcCtD
Metoprolol—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000237	0.00095	CcSEcCtD
Metoprolol—Tachycardia—Dexamethasone—multiple sclerosis	0.000236	0.000947	CcSEcCtD
Metoprolol—Tachycardia—Betamethasone—multiple sclerosis	0.000236	0.000947	CcSEcCtD
Metoprolol—Dyspepsia—Triamcinolone—multiple sclerosis	0.000235	0.000941	CcSEcCtD
Metoprolol—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000234	0.000939	CcSEcCtD
Metoprolol—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000234	0.000938	CcSEcCtD
Metoprolol—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000234	0.000938	CcSEcCtD
Metoprolol—Vertigo—Prednisone—multiple sclerosis	0.000232	0.00093	CcSEcCtD
Metoprolol—Eye disorder—Methotrexate—multiple sclerosis	0.000232	0.000929	CcSEcCtD
Metoprolol—Syncope—Prednisone—multiple sclerosis	0.000231	0.000929	CcSEcCtD
Metoprolol—Tinnitus—Methotrexate—multiple sclerosis	0.000231	0.000927	CcSEcCtD
Metoprolol—Urticaria—Prednisolone—multiple sclerosis	0.00023	0.000924	CcSEcCtD
Metoprolol—Cardiac disorder—Methotrexate—multiple sclerosis	0.00023	0.000923	CcSEcCtD
Metoprolol—Fatigue—Triamcinolone—multiple sclerosis	0.00023	0.000922	CcSEcCtD
Metoprolol—Fatigue—Methylprednisolone—multiple sclerosis	0.000229	0.00092	CcSEcCtD
Metoprolol—Pain—Triamcinolone—multiple sclerosis	0.000228	0.000915	CcSEcCtD
Metoprolol—Loss of consciousness—Prednisone—multiple sclerosis	0.000227	0.00091	CcSEcCtD
Metoprolol—Hypotension—Betamethasone—multiple sclerosis	0.000226	0.000907	CcSEcCtD
Metoprolol—Hypotension—Dexamethasone—multiple sclerosis	0.000226	0.000907	CcSEcCtD
Metoprolol—Angiopathy—Methotrexate—multiple sclerosis	0.000225	0.000902	CcSEcCtD
Metoprolol—Vomiting—Mitoxantrone—multiple sclerosis	0.000225	0.000901	CcSEcCtD
Metoprolol—Immune system disorder—Methotrexate—multiple sclerosis	0.000224	0.000898	CcSEcCtD
Metoprolol—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000223	0.000896	CcSEcCtD
Metoprolol—Hypertension—Prednisone—multiple sclerosis	0.000223	0.000894	CcSEcCtD
Metoprolol—Rash—Mitoxantrone—multiple sclerosis	0.000223	0.000894	CcSEcCtD
Metoprolol—Dermatitis—Mitoxantrone—multiple sclerosis	0.000223	0.000893	CcSEcCtD
Metoprolol—Headache—Mitoxantrone—multiple sclerosis	0.000221	0.000888	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.00022	0.000884	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.00022	0.000884	CcSEcCtD
Metoprolol—Arthralgia—Prednisone—multiple sclerosis	0.00022	0.000882	CcSEcCtD
Metoprolol—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00022	0.000881	CcSEcCtD
Metoprolol—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000219	0.000879	CcSEcCtD
Metoprolol—Anxiety—Prednisone—multiple sclerosis	0.000219	0.000878	CcSEcCtD
Metoprolol—Alopecia—Methotrexate—multiple sclerosis	0.000219	0.000878	CcSEcCtD
Metoprolol—Insomnia—Dexamethasone—multiple sclerosis	0.000219	0.000878	CcSEcCtD
Metoprolol—Insomnia—Betamethasone—multiple sclerosis	0.000219	0.000878	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000218	0.000875	CcSEcCtD
Metoprolol—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000218	0.000873	CcSEcCtD
Metoprolol—Paraesthesia—Dexamethasone—multiple sclerosis	0.000217	0.000871	CcSEcCtD
Metoprolol—Paraesthesia—Betamethasone—multiple sclerosis	0.000217	0.000871	CcSEcCtD
Metoprolol—Mental disorder—Methotrexate—multiple sclerosis	0.000217	0.000871	CcSEcCtD
Metoprolol—Hypersensitivity—Prednisolone—multiple sclerosis	0.000214	0.000857	CcSEcCtD
Metoprolol—Dyspepsia—Betamethasone—multiple sclerosis	0.000213	0.000854	CcSEcCtD
Metoprolol—Dyspepsia—Dexamethasone—multiple sclerosis	0.000213	0.000854	CcSEcCtD
Metoprolol—Urticaria—Triamcinolone—multiple sclerosis	0.000212	0.00085	CcSEcCtD
Metoprolol—Urticaria—Methylprednisolone—multiple sclerosis	0.000211	0.000848	CcSEcCtD
Metoprolol—Dysgeusia—Methotrexate—multiple sclerosis	0.000211	0.000847	CcSEcCtD
Metoprolol—Body temperature increased—Triamcinolone—multiple sclerosis	0.000211	0.000845	CcSEcCtD
Metoprolol—Oedema—Prednisone—multiple sclerosis	0.000211	0.000845	CcSEcCtD
Metoprolol—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00021	0.000844	CcSEcCtD
Metoprolol—Nausea—Mitoxantrone—multiple sclerosis	0.00021	0.000842	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000209	0.000838	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000209	0.000838	CcSEcCtD
Metoprolol—Fatigue—Betamethasone—multiple sclerosis	0.000209	0.000837	CcSEcCtD
Metoprolol—Fatigue—Dexamethasone—multiple sclerosis	0.000209	0.000837	CcSEcCtD
Metoprolol—Shock—Prednisone—multiple sclerosis	0.000207	0.000831	CcSEcCtD
Metoprolol—Pain—Dexamethasone—multiple sclerosis	0.000207	0.00083	CcSEcCtD
Metoprolol—Pain—Betamethasone—multiple sclerosis	0.000207	0.00083	CcSEcCtD
Metoprolol—Nervous system disorder—Prednisone—multiple sclerosis	0.000207	0.000829	CcSEcCtD
Metoprolol—Tachycardia—Prednisone—multiple sclerosis	0.000206	0.000825	CcSEcCtD
Metoprolol—Skin disorder—Prednisone—multiple sclerosis	0.000205	0.000821	CcSEcCtD
Metoprolol—Hyperhidrosis—Prednisone—multiple sclerosis	0.000204	0.000817	CcSEcCtD
Metoprolol—Vision blurred—Methotrexate—multiple sclerosis	0.000203	0.000816	CcSEcCtD
Metoprolol—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000199	0.0008	CcSEcCtD
Metoprolol—Feeling abnormal—Betamethasone—multiple sclerosis	0.000199	0.0008	CcSEcCtD
Metoprolol—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000198	0.000793	CcSEcCtD
Metoprolol—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000198	0.000793	CcSEcCtD
Metoprolol—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000196	0.000788	CcSEcCtD
Metoprolol—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000196	0.000786	CcSEcCtD
Metoprolol—Vertigo—Methotrexate—multiple sclerosis	0.000194	0.000777	CcSEcCtD
Metoprolol—Leukopenia—Methotrexate—multiple sclerosis	0.000193	0.000775	CcSEcCtD
Metoprolol—Urticaria—Dexamethasone—multiple sclerosis	0.000192	0.000771	CcSEcCtD
Metoprolol—Urticaria—Betamethasone—multiple sclerosis	0.000192	0.000771	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000192	0.00077	CcSEcCtD
Metoprolol—Dizziness—Prednisolone—multiple sclerosis	0.000192	0.000769	CcSEcCtD
Metoprolol—Asthenia—Triamcinolone—multiple sclerosis	0.000191	0.000767	CcSEcCtD
Metoprolol—Abdominal pain—Betamethasone—multiple sclerosis	0.000191	0.000767	CcSEcCtD
Metoprolol—Body temperature increased—Betamethasone—multiple sclerosis	0.000191	0.000767	CcSEcCtD
Metoprolol—Abdominal pain—Dexamethasone—multiple sclerosis	0.000191	0.000767	CcSEcCtD
Metoprolol—Body temperature increased—Dexamethasone—multiple sclerosis	0.000191	0.000767	CcSEcCtD
Metoprolol—Asthenia—Methylprednisolone—multiple sclerosis	0.000191	0.000766	CcSEcCtD
Metoprolol—Insomnia—Prednisone—multiple sclerosis	0.000191	0.000764	CcSEcCtD
Metoprolol—Paraesthesia—Prednisone—multiple sclerosis	0.000189	0.000759	CcSEcCtD
Metoprolol—Pruritus—Triamcinolone—multiple sclerosis	0.000189	0.000757	CcSEcCtD
Metoprolol—Pruritus—Methylprednisolone—multiple sclerosis	0.000188	0.000755	CcSEcCtD
Metoprolol—Dyspepsia—Prednisone—multiple sclerosis	0.000185	0.000744	CcSEcCtD
Metoprolol—Arthralgia—Methotrexate—multiple sclerosis	0.000184	0.000737	CcSEcCtD
Metoprolol—Chest pain—Methotrexate—multiple sclerosis	0.000184	0.000737	CcSEcCtD
Metoprolol—Rash—Prednisolone—multiple sclerosis	0.000183	0.000733	CcSEcCtD
Metoprolol—Dermatitis—Prednisolone—multiple sclerosis	0.000183	0.000733	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000182	0.000732	CcSEcCtD
Metoprolol—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000182	0.00073	CcSEcCtD
Metoprolol—Fatigue—Prednisone—multiple sclerosis	0.000182	0.000729	CcSEcCtD
Metoprolol—Headache—Prednisolone—multiple sclerosis	0.000182	0.000729	CcSEcCtD
Metoprolol—Constipation—Prednisone—multiple sclerosis	0.00018	0.000723	CcSEcCtD
Metoprolol—Confusional state—Methotrexate—multiple sclerosis	0.000178	0.000712	CcSEcCtD
Metoprolol—Dizziness—Triamcinolone—multiple sclerosis	0.000176	0.000707	CcSEcCtD
Metoprolol—Dizziness—Methylprednisolone—multiple sclerosis	0.000176	0.000706	CcSEcCtD
Metoprolol—Feeling abnormal—Prednisone—multiple sclerosis	0.000174	0.000696	CcSEcCtD
Metoprolol—Asthenia—Betamethasone—multiple sclerosis	0.000174	0.000696	CcSEcCtD
Metoprolol—Asthenia—Dexamethasone—multiple sclerosis	0.000174	0.000696	CcSEcCtD
Metoprolol—Nervous system disorder—Methotrexate—multiple sclerosis	0.000173	0.000693	CcSEcCtD
Metoprolol—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000172	0.000691	CcSEcCtD
Metoprolol—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000172	0.000691	CcSEcCtD
Metoprolol—Nausea—Prednisolone—multiple sclerosis	0.000172	0.000691	CcSEcCtD
Metoprolol—Pruritus—Dexamethasone—multiple sclerosis	0.000171	0.000687	CcSEcCtD
Metoprolol—Pruritus—Betamethasone—multiple sclerosis	0.000171	0.000687	CcSEcCtD
Metoprolol—Skin disorder—Methotrexate—multiple sclerosis	0.000171	0.000686	CcSEcCtD
Metoprolol—Hyperhidrosis—Methotrexate—multiple sclerosis	0.00017	0.000683	CcSEcCtD
Metoprolol—Vomiting—Triamcinolone—multiple sclerosis	0.00017	0.00068	CcSEcCtD
Metoprolol—Vomiting—Methylprednisolone—multiple sclerosis	0.000169	0.000678	CcSEcCtD
Metoprolol—Rash—Triamcinolone—multiple sclerosis	0.000168	0.000674	CcSEcCtD
Metoprolol—Dermatitis—Triamcinolone—multiple sclerosis	0.000168	0.000674	CcSEcCtD
Metoprolol—Rash—Methylprednisolone—multiple sclerosis	0.000168	0.000673	CcSEcCtD
Metoprolol—Dermatitis—Methylprednisolone—multiple sclerosis	0.000168	0.000672	CcSEcCtD
Metoprolol—Urticaria—Prednisone—multiple sclerosis	0.000167	0.000671	CcSEcCtD
Metoprolol—Headache—Triamcinolone—multiple sclerosis	0.000167	0.00067	CcSEcCtD
Metoprolol—Headache—Methylprednisolone—multiple sclerosis	0.000167	0.000668	CcSEcCtD
Metoprolol—Abdominal pain—Prednisone—multiple sclerosis	0.000167	0.000668	CcSEcCtD
Metoprolol—Body temperature increased—Prednisone—multiple sclerosis	0.000167	0.000668	CcSEcCtD
Metoprolol—Diarrhoea—Betamethasone—multiple sclerosis	0.000166	0.000664	CcSEcCtD
Metoprolol—Diarrhoea—Dexamethasone—multiple sclerosis	0.000166	0.000664	CcSEcCtD
Metoprolol—Hypotension—Methotrexate—multiple sclerosis	0.000165	0.00066	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.00016	0.000643	CcSEcCtD
Metoprolol—Dizziness—Dexamethasone—multiple sclerosis	0.00016	0.000642	CcSEcCtD
Metoprolol—Dizziness—Betamethasone—multiple sclerosis	0.00016	0.000642	CcSEcCtD
Metoprolol—Insomnia—Methotrexate—multiple sclerosis	0.000159	0.000639	CcSEcCtD
Metoprolol—Nausea—Triamcinolone—multiple sclerosis	0.000158	0.000635	CcSEcCtD
Metoprolol—Paraesthesia—Methotrexate—multiple sclerosis	0.000158	0.000634	CcSEcCtD
Metoprolol—Nausea—Methylprednisolone—multiple sclerosis	0.000158	0.000634	CcSEcCtD
Metoprolol—Dyspnoea—Methotrexate—multiple sclerosis	0.000157	0.00063	CcSEcCtD
Metoprolol—Somnolence—Methotrexate—multiple sclerosis	0.000157	0.000628	CcSEcCtD
Metoprolol—Hypersensitivity—Prednisone—multiple sclerosis	0.000155	0.000623	CcSEcCtD
Metoprolol—Dyspepsia—Methotrexate—multiple sclerosis	0.000155	0.000622	CcSEcCtD
Metoprolol—Vomiting—Betamethasone—multiple sclerosis	0.000154	0.000617	CcSEcCtD
Metoprolol—Vomiting—Dexamethasone—multiple sclerosis	0.000154	0.000617	CcSEcCtD
Metoprolol—Rash—Betamethasone—multiple sclerosis	0.000153	0.000612	CcSEcCtD
Metoprolol—Rash—Dexamethasone—multiple sclerosis	0.000153	0.000612	CcSEcCtD
Metoprolol—Dermatitis—Dexamethasone—multiple sclerosis	0.000152	0.000611	CcSEcCtD
Metoprolol—Dermatitis—Betamethasone—multiple sclerosis	0.000152	0.000611	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000152	0.00061	CcSEcCtD
Metoprolol—Fatigue—Methotrexate—multiple sclerosis	0.000152	0.000609	CcSEcCtD
Metoprolol—Headache—Betamethasone—multiple sclerosis	0.000152	0.000608	CcSEcCtD
Metoprolol—Headache—Dexamethasone—multiple sclerosis	0.000152	0.000608	CcSEcCtD
Metoprolol—Asthenia—Prednisone—multiple sclerosis	0.000151	0.000606	CcSEcCtD
Metoprolol—Pain—Methotrexate—multiple sclerosis	0.000151	0.000604	CcSEcCtD
Metoprolol—Pruritus—Prednisone—multiple sclerosis	0.000149	0.000598	CcSEcCtD
Metoprolol—Feeling abnormal—Methotrexate—multiple sclerosis	0.000145	0.000582	CcSEcCtD
Metoprolol—Diarrhoea—Prednisone—multiple sclerosis	0.000144	0.000578	CcSEcCtD
Metoprolol—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000144	0.000578	CcSEcCtD
Metoprolol—Nausea—Dexamethasone—multiple sclerosis	0.000144	0.000576	CcSEcCtD
Metoprolol—Nausea—Betamethasone—multiple sclerosis	0.000144	0.000576	CcSEcCtD
Metoprolol—Urticaria—Methotrexate—multiple sclerosis	0.00014	0.000561	CcSEcCtD
Metoprolol—Dizziness—Prednisone—multiple sclerosis	0.000139	0.000559	CcSEcCtD
Metoprolol—Abdominal pain—Methotrexate—multiple sclerosis	0.000139	0.000558	CcSEcCtD
Metoprolol—Body temperature increased—Methotrexate—multiple sclerosis	0.000139	0.000558	CcSEcCtD
Metoprolol—Vomiting—Prednisone—multiple sclerosis	0.000134	0.000537	CcSEcCtD
Metoprolol—Rash—Prednisone—multiple sclerosis	0.000133	0.000533	CcSEcCtD
Metoprolol—Dermatitis—Prednisone—multiple sclerosis	0.000133	0.000532	CcSEcCtD
Metoprolol—Headache—Prednisone—multiple sclerosis	0.000132	0.000529	CcSEcCtD
Metoprolol—Hypersensitivity—Methotrexate—multiple sclerosis	0.00013	0.00052	CcSEcCtD
Metoprolol—Asthenia—Methotrexate—multiple sclerosis	0.000126	0.000507	CcSEcCtD
Metoprolol—Nausea—Prednisone—multiple sclerosis	0.000125	0.000502	CcSEcCtD
Metoprolol—Pruritus—Methotrexate—multiple sclerosis	0.000125	0.0005	CcSEcCtD
Metoprolol—Diarrhoea—Methotrexate—multiple sclerosis	0.00012	0.000483	CcSEcCtD
Metoprolol—Dizziness—Methotrexate—multiple sclerosis	0.000116	0.000467	CcSEcCtD
Metoprolol—Vomiting—Methotrexate—multiple sclerosis	0.000112	0.000449	CcSEcCtD
Metoprolol—Rash—Methotrexate—multiple sclerosis	0.000111	0.000445	CcSEcCtD
Metoprolol—Dermatitis—Methotrexate—multiple sclerosis	0.000111	0.000445	CcSEcCtD
Metoprolol—Headache—Methotrexate—multiple sclerosis	0.00011	0.000442	CcSEcCtD
Metoprolol—Nausea—Methotrexate—multiple sclerosis	0.000105	0.00042	CcSEcCtD
Metoprolol—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.39e-05	0.00296	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	5.39e-05	0.00296	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	5.36e-05	0.00294	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—FAS—multiple sclerosis	5.35e-05	0.00294	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	5.32e-05	0.00292	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	5.26e-05	0.00289	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	5.24e-05	0.00288	CbGpPWpGaD
Metoprolol—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.96e-05	0.00272	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	4.95e-05	0.00271	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—S1PR1—multiple sclerosis	4.85e-05	0.00266	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	4.84e-05	0.00265	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	4.81e-05	0.00264	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—S1PR1—multiple sclerosis	4.75e-05	0.0026	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—CCL3—multiple sclerosis	4.51e-05	0.00247	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—SRM—multiple sclerosis	4.47e-05	0.00245	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	4.45e-05	0.00244	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—CD80—multiple sclerosis	4.44e-05	0.00244	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—CCL3—multiple sclerosis	4.41e-05	0.00242	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—S1PR1—multiple sclerosis	4.41e-05	0.00242	CbGpPWpGaD
Metoprolol—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.37e-05	0.0024	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	4.36e-05	0.00239	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—PTGER4—multiple sclerosis	4.34e-05	0.00238	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.34e-05	0.00238	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—S1PR1—multiple sclerosis	4.31e-05	0.00237	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—PTGER4—multiple sclerosis	4.25e-05	0.00233	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—CXCR3—multiple sclerosis	4.2e-05	0.0023	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—RGS1—multiple sclerosis	4.13e-05	0.00226	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—CXCR3—multiple sclerosis	4.1e-05	0.00225	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—CCR2—multiple sclerosis	4.08e-05	0.00224	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—RGS1—multiple sclerosis	4.04e-05	0.00221	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	4.03e-05	0.00221	CbGpPWpGaD
Metoprolol—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.02e-05	0.0022	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—CCR2—multiple sclerosis	3.99e-05	0.00219	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.96e-05	0.00217	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.96e-05	0.00217	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	3.95e-05	0.00217	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	3.94e-05	0.00216	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—GPR65—multiple sclerosis	3.91e-05	0.00215	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	3.85e-05	0.00211	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.83e-05	0.0021	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	3.83e-05	0.0021	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—GPR65—multiple sclerosis	3.83e-05	0.0021	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—CNR1—multiple sclerosis	3.77e-05	0.00207	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	3.75e-05	0.00206	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—RGS1—multiple sclerosis	3.75e-05	0.00206	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—CNR1—multiple sclerosis	3.68e-05	0.00202	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—RGS1—multiple sclerosis	3.67e-05	0.00201	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—CCR1—multiple sclerosis	3.58e-05	0.00196	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—CXCL13—multiple sclerosis	3.58e-05	0.00196	CbGpPWpGaD
Metoprolol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	3.58e-05	0.00196	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—GPR65—multiple sclerosis	3.55e-05	0.00195	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	3.51e-05	0.00193	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—CCR1—multiple sclerosis	3.5e-05	0.00192	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—CXCL13—multiple sclerosis	3.5e-05	0.00192	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—GPR65—multiple sclerosis	3.48e-05	0.00191	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	3.45e-05	0.00189	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—LINGO1—multiple sclerosis	3.44e-05	0.00188	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—CXCL10—multiple sclerosis	3.39e-05	0.00186	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	3.38e-05	0.00185	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—LINGO1—multiple sclerosis	3.36e-05	0.00184	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—CXCL10—multiple sclerosis	3.32e-05	0.00182	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—CCR1—multiple sclerosis	3.25e-05	0.00178	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—CXCL13—multiple sclerosis	3.25e-05	0.00178	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CCR1—multiple sclerosis	3.18e-05	0.00174	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CXCL13—multiple sclerosis	3.18e-05	0.00174	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CYP24A1—multiple sclerosis	3.15e-05	0.00173	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CYP27B1—multiple sclerosis	3.15e-05	0.00173	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	3.13e-05	0.00172	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—IL2—multiple sclerosis	3.12e-05	0.00171	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	3.09e-05	0.00169	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3e-05	0.00164	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—TAGAP—multiple sclerosis	2.98e-05	0.00163	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—CCL5—multiple sclerosis	2.92e-05	0.0016	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—TAGAP—multiple sclerosis	2.91e-05	0.0016	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—GPC5—multiple sclerosis	2.88e-05	0.00158	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—CCL5—multiple sclerosis	2.86e-05	0.00157	CbGpPWpGaD
Metoprolol—SLC22A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.72e-05	0.00149	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	2.7e-05	0.00148	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.64e-05	0.00145	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	2.64e-05	0.00145	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	2.64e-05	0.00145	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—CCR5—multiple sclerosis	2.63e-05	0.00144	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—S1PR1—multiple sclerosis	2.6e-05	0.00143	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	2.58e-05	0.00142	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—CCR5—multiple sclerosis	2.57e-05	0.00141	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—S1PR1—multiple sclerosis	2.55e-05	0.0014	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—GPC5—multiple sclerosis	2.53e-05	0.00139	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—SRM—multiple sclerosis	2.5e-05	0.00137	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—GPC5—multiple sclerosis	2.48e-05	0.00136	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—PTGER4—multiple sclerosis	2.45e-05	0.00135	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—SRM—multiple sclerosis	2.44e-05	0.00134	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	2.43e-05	0.00134	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—PTGER4—multiple sclerosis	2.4e-05	0.00132	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—RRM1—multiple sclerosis	2.39e-05	0.00131	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—CXCR3—multiple sclerosis	2.37e-05	0.0013	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.37e-05	0.0013	CbGpPWpGaD
Metoprolol—CYP2C19—Biological oxidations—POMC—multiple sclerosis	2.32e-05	0.00127	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—CXCR3—multiple sclerosis	2.32e-05	0.00127	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—CCL3—multiple sclerosis	2.32e-05	0.00127	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—CCR2—multiple sclerosis	2.31e-05	0.00126	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—SRM—multiple sclerosis	2.3e-05	0.00126	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—TNF—multiple sclerosis	2.27e-05	0.00125	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CCL3—multiple sclerosis	2.27e-05	0.00124	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—CCR2—multiple sclerosis	2.26e-05	0.00124	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—PTGER4—multiple sclerosis	2.23e-05	0.00122	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—RGS1—multiple sclerosis	2.21e-05	0.00121	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—PTGER4—multiple sclerosis	2.18e-05	0.0012	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—RGS1—multiple sclerosis	2.17e-05	0.00119	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—CXCR3—multiple sclerosis	2.15e-05	0.00118	CbGpPWpGaD
Metoprolol—CYP2D6—Biological oxidations—POMC—multiple sclerosis	2.13e-05	0.00117	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—CNR1—multiple sclerosis	2.13e-05	0.00117	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CXCR3—multiple sclerosis	2.11e-05	0.00116	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—GPR65—multiple sclerosis	2.1e-05	0.00115	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.09e-05	0.00115	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—CCR2—multiple sclerosis	2.09e-05	0.00115	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—CNR1—multiple sclerosis	2.08e-05	0.00114	CbGpPWpGaD
Metoprolol—SLC22A2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.08e-05	0.00114	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—POMC—multiple sclerosis	2.06e-05	0.00113	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—GPR65—multiple sclerosis	2.05e-05	0.00113	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CCR2—multiple sclerosis	2.05e-05	0.00112	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—CCL2—multiple sclerosis	2.01e-05	0.0011	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—POMC—multiple sclerosis	2.01e-05	0.0011	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—CCL2—multiple sclerosis	1.97e-05	0.00108	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—CNR1—multiple sclerosis	1.93e-05	0.00106	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CXCL13—multiple sclerosis	1.92e-05	0.00105	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CCR1—multiple sclerosis	1.92e-05	0.00105	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—CXCL10—multiple sclerosis	1.92e-05	0.00105	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CNR1—multiple sclerosis	1.89e-05	0.00104	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CCR1—multiple sclerosis	1.88e-05	0.00103	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CXCL13—multiple sclerosis	1.88e-05	0.00103	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—CXCL10—multiple sclerosis	1.87e-05	0.00103	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	1.76e-05	0.000968	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	1.76e-05	0.000968	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—CXCL10—multiple sclerosis	1.74e-05	0.000954	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.72e-05	0.000946	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CYP27B1—multiple sclerosis	1.72e-05	0.000944	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CYP24A1—multiple sclerosis	1.72e-05	0.000944	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CXCL10—multiple sclerosis	1.7e-05	0.000934	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—CCL5—multiple sclerosis	1.65e-05	0.000905	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	1.62e-05	0.00089	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	1.62e-05	0.00089	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—CCL5—multiple sclerosis	1.61e-05	0.000885	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GPC5—multiple sclerosis	1.61e-05	0.000885	CbGpPWpGaD
Metoprolol—SLC22A2—Neuronal System—MAPK1—multiple sclerosis	1.59e-05	0.000873	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GPC5—multiple sclerosis	1.58e-05	0.000864	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—CCL5—multiple sclerosis	1.5e-05	0.000822	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—CCR5—multiple sclerosis	1.49e-05	0.000815	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GPC5—multiple sclerosis	1.48e-05	0.000814	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CCL5—multiple sclerosis	1.47e-05	0.000804	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—IL2RA—multiple sclerosis	1.46e-05	0.000803	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—CCR5—multiple sclerosis	1.45e-05	0.000797	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—IL2RA—multiple sclerosis	1.43e-05	0.000786	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.38e-05	0.000757	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—BCHE—multiple sclerosis	1.37e-05	0.000753	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CCL3—multiple sclerosis	1.37e-05	0.00075	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—CCR5—multiple sclerosis	1.35e-05	0.00074	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CCL3—multiple sclerosis	1.34e-05	0.000734	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—RRM1—multiple sclerosis	1.34e-05	0.000733	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—IL2RA—multiple sclerosis	1.33e-05	0.000729	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CCR5—multiple sclerosis	1.32e-05	0.000724	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PTGER4—multiple sclerosis	1.32e-05	0.000722	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—RRM1—multiple sclerosis	1.31e-05	0.000716	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—IL2RA—multiple sclerosis	1.3e-05	0.000714	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PGR—multiple sclerosis	1.3e-05	0.000711	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PTGER4—multiple sclerosis	1.29e-05	0.000707	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CXCR3—multiple sclerosis	1.27e-05	0.000698	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PGR—multiple sclerosis	1.27e-05	0.000696	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CD28—multiple sclerosis	1.26e-05	0.000691	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CXCR3—multiple sclerosis	1.24e-05	0.000682	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CCR2—multiple sclerosis	1.24e-05	0.000679	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CD28—multiple sclerosis	1.23e-05	0.000676	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.23e-05	0.000675	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CCR2—multiple sclerosis	1.21e-05	0.000664	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.2e-05	0.00066	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.2e-05	0.000659	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.18e-05	0.000646	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—POMC—multiple sclerosis	1.16e-05	0.000637	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CNR1—multiple sclerosis	1.14e-05	0.000626	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—POMC—multiple sclerosis	1.14e-05	0.000623	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.12e-05	0.000615	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CNR1—multiple sclerosis	1.12e-05	0.000613	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—POMC—multiple sclerosis	1.05e-05	0.000578	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.04e-05	0.000569	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—CCL2—multiple sclerosis	1.03e-05	0.000566	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—POMC—multiple sclerosis	1.03e-05	0.000566	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CXCL10—multiple sclerosis	1.03e-05	0.000564	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CCL2—multiple sclerosis	1.01e-05	0.000554	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CXCL10—multiple sclerosis	1.01e-05	0.000552	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—TYK2—multiple sclerosis	9.37e-06	0.000514	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—TYK2—multiple sclerosis	9.17e-06	0.000503	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CD86—multiple sclerosis	8.99e-06	0.000493	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.91e-06	0.000489	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CCL5—multiple sclerosis	8.85e-06	0.000485	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CD86—multiple sclerosis	8.79e-06	0.000482	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CCL5—multiple sclerosis	8.66e-06	0.000475	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—IL2—multiple sclerosis	8.59e-06	0.000471	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—IL2—multiple sclerosis	8.4e-06	0.000461	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—APOE—multiple sclerosis	8.25e-06	0.000453	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—SPP1—multiple sclerosis	8.2e-06	0.000449	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.12e-06	0.000446	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—SPP1—multiple sclerosis	8.02e-06	0.00044	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CCR5—multiple sclerosis	7.97e-06	0.000437	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IL2RA—multiple sclerosis	7.86e-06	0.000431	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CCR5—multiple sclerosis	7.8e-06	0.000428	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—IL2—multiple sclerosis	7.8e-06	0.000428	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IL2RA—multiple sclerosis	7.69e-06	0.000422	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—BCHE—multiple sclerosis	7.68e-06	0.000421	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—IL2—multiple sclerosis	7.63e-06	0.000418	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	7.54e-06	0.000414	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—BCHE—multiple sclerosis	7.5e-06	0.000411	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—APOE—multiple sclerosis	7.25e-06	0.000398	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—APOE—multiple sclerosis	7.1e-06	0.000389	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—POMC—multiple sclerosis	7.09e-06	0.000389	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—BCHE—multiple sclerosis	7.06e-06	0.000387	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CD80—multiple sclerosis	6.56e-06	0.00036	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—ALB—multiple sclerosis	6.46e-06	0.000355	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CD80—multiple sclerosis	6.41e-06	0.000352	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—POMC—multiple sclerosis	6.23e-06	0.000342	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CCL2—multiple sclerosis	6.1e-06	0.000334	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—POMC—multiple sclerosis	6.1e-06	0.000334	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—MAPK1—multiple sclerosis	5.96e-06	0.000327	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CCL2—multiple sclerosis	5.96e-06	0.000327	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—MAPK1—multiple sclerosis	5.83e-06	0.00032	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—TYK2—multiple sclerosis	5.54e-06	0.000304	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—TYK2—multiple sclerosis	5.42e-06	0.000297	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—APOE—multiple sclerosis	4.62e-06	0.000253	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IL2—multiple sclerosis	4.61e-06	0.000253	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—IL6—multiple sclerosis	4.58e-06	0.000251	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—APOE—multiple sclerosis	4.51e-06	0.000247	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IL2—multiple sclerosis	4.51e-06	0.000247	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—IL6—multiple sclerosis	4.48e-06	0.000246	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MMP9—multiple sclerosis	4.36e-06	0.000239	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MMP9—multiple sclerosis	4.26e-06	0.000234	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—APOE—multiple sclerosis	4.25e-06	0.000233	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—POMC—multiple sclerosis	3.97e-06	0.000218	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—STAT3—multiple sclerosis	3.88e-06	0.000213	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—POMC—multiple sclerosis	3.87e-06	0.000212	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—STAT3—multiple sclerosis	3.79e-06	0.000208	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—POMC—multiple sclerosis	3.65e-06	0.0002	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ALB—multiple sclerosis	3.62e-06	0.000198	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MYC—multiple sclerosis	3.6e-06	0.000198	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—TGFB1—multiple sclerosis	3.59e-06	0.000197	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ALB—multiple sclerosis	3.53e-06	0.000194	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MAPK1—multiple sclerosis	3.52e-06	0.000193	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MYC—multiple sclerosis	3.52e-06	0.000193	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—TGFB1—multiple sclerosis	3.51e-06	0.000193	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MAPK1—multiple sclerosis	3.45e-06	0.000189	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ALB—multiple sclerosis	3.33e-06	0.000183	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IL6—multiple sclerosis	2.71e-06	0.000148	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IL6—multiple sclerosis	2.65e-06	0.000145	CbGpPWpGaD
